filed
on 17 Apr 2024
Last Applicant/ Owned by
215 First Street
Cambridge
MA
02142
Serial Number
97368285 filed on 18th Apr 2022
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, geneticRead More
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
No 97368285
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 17th Apr 2024 | SOU TEAS EXTENSION RECEIVED |
| 17th Apr 2024 | SOU EXTENSION 2 FILED |
| 17th Apr 2024 | SOU EXTENSION 2 GRANTED |
| 31st Oct 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 27th Oct 2023 | SOU TEAS EXTENSION RECEIVED |
| 27th Oct 2023 | SOU EXTENSION 1 FILED |
| 27th Oct 2023 | SOU EXTENSION 1 GRANTED |
| 09th May 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 14th Mar 2023 | PUBLISHED FOR OPPOSITION |
| 14th Mar 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
